UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$940M |
| 2 |
Pinduoduo
PDD
|
+$928M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$811M |
| 4 |
NVIDIA
NVDA
|
+$747M |
| 5 |
Amphenol
APH
|
+$517M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$21.2B |
| 2 |
Amazon
AMZN
|
+$12.4B |
| 3 |
Bank of America
BAC
|
+$1.75B |
| 4 |
Applied Materials
AMAT
|
+$1.26B |
| 5 |
Prologis
PLD
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.66% |
| 2 | Financials | 14.85% |
| 3 | Healthcare | 13.16% |
| 4 | Communication Services | 8.88% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
Phathom Pharmaceuticals
PHAT
$708M
| $625K | ﹤0.01% |
99,744
-18,059
| -15% | -$110K |
|
2452
GoodRx Holdings
GDRX
$1.04B
| $618K | ﹤0.01% |
140,249
-9,696
| -6% | -$45.5K |
|
|
VTLE
2453
DELISTED
Vital Energy
VTLE
| $617K | ﹤0.01% |
29,067
+2,343
| +9% | +$67.9K |
|
2454
Erasca
ERAS
$6.3B
| $610K | ﹤0.01% |
445,580
+811
| +0.2% | +$1.39K |
|
|
VERV
2455
DELISTED
Verve Therapeutics
VERV
| $610K | ﹤0.01% |
133,566
+13,748
| +11% | +$92.1K |
|
2456
Cullinan Oncology
CGEM
$1.01B
| $608K | ﹤0.01% |
80,353
-11,439
| -12% | -$110K |
|
|
ARIS
2457
Aris Mining
ARIS
$2.76B
| $606K | ﹤0.01% |
130,505
| – | – |
|
2458
Mativ Holdings
MATV
$481M
| $601K | ﹤0.01% |
96,459
+1,712
| +2% | +$14K |
|
2459
Evolv Technologies
EVLV
$995M
| $599K | ﹤0.01% |
191,841
+17,195
| +10% | +$60.4K |
|
2460
Standard BioTools
LAB
$340M
| $599K | ﹤0.01% |
554,203
| – | – |
|
|
DEC
2461
Diversified Energy Company
DEC
$930M
| $597K | ﹤0.01% |
44,182
+14,065
| +47% | +$208K |
|
2462
NovaGold Resources
NG
$2.56B
| $592K | ﹤0.01% |
202,627
| – | – |
|
2463
Pulse Biosciences
PLSE
$2.43B
| $588K | ﹤0.01% |
36,531
-1,777
| -5% | -$33.1K |
|
2464
The RealReal
REAL
$1.46B
| $586K | ﹤0.01% |
+108,659
| New | +$824K |
|
2465
Ambev
ABEV
$48.1B
| $583K | ﹤0.01% |
250,000
+117,400
| +89% | +$235K |
|
2466
Bristow Group
VTOL
$1.34B
| $582K | ﹤0.01% |
18,433
-7,969
| -30% | -$274K |
|
2467
Covenant Logistics
CVLG
$894M
| $582K | ﹤0.01% |
26,207
+997
| +4% | +$25.7K |
|
2468
Hagerty
HGTY
$1.17B
| $580K | ﹤0.01% |
64,205
| – | – |
|
2469
GigaCloud Technology
GCT
$1.63B
| $580K | ﹤0.01% |
40,853
+4,435
| +12% | +$80.9K |
|
2470
Midland States Bancorp
MSBI
$699M
| $580K | ﹤0.01% |
33,873
| – | – |
|
2471
Paymentus
PAY
$4.29B
| $573K | ﹤0.01% |
21,954
-24,354
| -53% | -$721K |
|
2472
Harte-Hanks
HHS
$16.2M
| $564K | ﹤0.01% |
+117,500
| New | +$600K |
|
2473
SelectQuote
SLQT
$132M
| $564K | ﹤0.01% |
+168,724
| New | +$716K |
|
2474
Hovnanian Enterprises
HOV
$726M
| $563K | ﹤0.01% |
5,379
-4,526
| -46% | -$546K |
|
2475
Capricor Therapeutics
CAPR
$223M
| $561K | ﹤0.01% |
59,166
+25,668
| +77% | +$356K |
|
Similar funds
UBS AM's Q1 2025 Portfolio in Review
As of Q1 2025, UBS AM held 2,732 positions worth $391B, down 8.9% from $429B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
UBS AM withdrew a net $17.8B in Q1 2025, closing 94 positions and reducing 646 holdings. Its most notable exit was Banco Bradesco, an estimated $70.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 35% a quarter earlier, followed by Financials and Healthcare.
Against the trend, UBS AM opened a new position in iShares US Treasury Bond ETF worth $189M.
- UBS AM's largest Q1 2025 buy was iShares US Treasury Bond ETF: 8,213,229 shares worth $189M.
- UBS AM added most to Microsoft in Q1 2025, an estimated $940M increase.
- UBS AM's biggest Q1 2025 reduction was Apple, cutting an estimated $21.2B.
- UBS AM fully exited Banco Bradesco in Q1 2025, selling an estimated $70.6M.
- UBS AM's ten largest holdings make up 24% of its $391B portfolio in Q1 2025.
- UBS AM opened 103 new positions and closed 94 in Q1 2025.
- UBS AM's portfolio value fell 8.9% quarter-over-quarter to $391B.
Based on UBS AM's 13F filing for Q1 2025, filed 19 May 2025.